Search - tctmd.com

Displaying 261 - 280 of 573

Sort: Relevancy | Date

News Daily News

Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease

Yael L. Maxwell

September 15, 2017

News Features

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

Todd Neale

September 15, 2017

News Daily News

Hormone Therapy Doesn’t Impact Long-term All-Cause, CV, or Cancer Mortality: WHI Analysis

Caitlin E. Cox

September 14, 2017

News Conference News VIVA 2017

EVAR Outcomes Equivalent Between Men and Women, Registries Show

L.A. McKeown

September 14, 2017

News Daily News

Another Study Challenges Notion of ‘Healthy Obese’

L.A. McKeown

September 11, 2017

News Industry News

The Cardiovascular Research Foundation Appoints Dr. Juan F. Granada as President and Chief Executive Officer

September 11, 2017

News Opinion Editor's Corner ESC 2017

My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back

Shelley Wood

September 08, 2017

News Daily News

No More Absorb BVS: Abbott Puts a Stop to Sales

Caitlin E. Cox

September 08, 2017

News Industry News

Micro Interventional Devices, Inc.™ Completes First Clinical Tricuspid Bicuspidization Procedure Utilizing MIA™ Technology

September 07, 2017

News Daily News

Appropriate Use Criteria Released for Imaging in Valvular Heart Disease

Caitlin E. Cox

September 06, 2017

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2017

Caitlin E. Cox

August 31, 2017

News Daily News

Popular CV Risk Calculator Is Not Accurate Among Patients at Low Socioeconomic Standing

Yael L. Maxwell

August 31, 2017

News Opinion Fellow Talk

Cost Awareness and Fellowship Education

Amit K. Gupta, MBBS, MD

August 31, 2017

Presentation iASSESS 2017

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Presenter: Rahul Sakhuja, Zoltan Turi

August 30, 2017

Presentation iASSESS 2017

Complications of Structural Heart Disease Intervention - Part 2

Presenter: Mauricio G. Cohen

August 30, 2017

News Conference News ESC 2017

Women at High Cardiovascular Risk Unlikely to Get to Low LDL Targets

Michael O'Riordan

August 30, 2017

News Industry News

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

August 30, 2017

Presentation iASSESS 2017

Congenital Heart Disease

Presenter: John P. Breinholt

August 30, 2017

Presentation iASSESS 2017

Complications of Structural Heart Disease Intervention - Part 1

Presenter: George Hanzel

August 30, 2017

News Conference News ESC 2017

Under Pressure: PRECISION Substudy Shows Adverse BP Effects of Ibuprofen

L.A. McKeown

August 30, 2017

Advertisement

Mobile Health Technologies May Boost Diagnosis, Care for Patients With Structural Heart Disease

COMPASS: All Signs Point to Big Impact in CAD and PAD, Experts Predict

Hormone Therapy Doesn’t Impact Long-term All-Cause, CV, or Cancer Mortality: WHI Analysis

EVAR Outcomes Equivalent Between Men and Women, Registries Show

Another Study Challenges Notion of ‘Healthy Obese’

The Cardiovascular Research Foundation Appoints Dr. Juan F. Granada as President and Chief Executive Officer

My Takeaways From ESC 2017: That Lovin’ Feeling? Barcelona Brings It Back

No More Absorb BVS: Abbott Puts a Stop to Sales

Micro Interventional Devices, Inc.™ Completes First Clinical Tricuspid Bicuspidization Procedure Utilizing MIA™ Technology

Appropriate Use Criteria Released for Imaging in Valvular Heart Disease

TCTMD’s Top 10 Most Popular Stories for August 2017

Popular CV Risk Calculator Is Not Accurate Among Patients at Low Socioeconomic Standing

Cost Awareness and Fellowship Education

Valvular Heart Disease: Aortic Valvuloplasty and TAVR

Complications of Structural Heart Disease Intervention - Part 2

Women at High Cardiovascular Risk Unlikely to Get to Low LDL Targets

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

Congenital Heart Disease

Complications of Structural Heart Disease Intervention - Part 1

Under Pressure: PRECISION Substudy Shows Adverse BP Effects of Ibuprofen

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content